Evidence map›Paper›PMID 29751826›Full record

ArticleBMC medical genetics2018

Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population.

Godwill Azeh Engwa, Friday Nweke Nwalo, Claribel Chidimma Chikezie, Christie Oby Onyia, Opeolu Oyejide Ojo, Wilfred Fon Mbacham, Benjamin Ewa Ubi

Open access · goldAbstract read
In one paragraph

Article in BMC medical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Significant association ofJournal of diabetes and metabolic disorders · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Godwill Azeh EngwaBiochemistry, Department of Chemical Sciences, Godfrey Okoye University, P.M.B 01014, Thinkers Corner, Enugu, Nigeria. engwagodwill@gmail.com.
Friday Nweke NwaloDepartment of Biotechnology, Federal University, Ndufu-Alike Ikwo (FUNAI), P.M.B. 1010, Abakaliki, Nigeria.
Claribel Chidimma ChikezieDepartment of Biotechnology, Godfrey Okoye University, P.M.B 01014, Thinkers Corner, Enugu, Nigeria.
Christie Oby OnyiaDepartment of Biotechnology, Godfrey Okoye University, P.M.B 01014, Thinkers Corner, Enugu, Nigeria.
Opeolu Oyejide OjoDepartment of Biology, Chemistry and Forensic Science, School of Sciences, University of Wolverhampton, Wolverhampton, WV1 1LY, UK.
Wilfred Fon MbachamLaboratory for Public Health Research Biotechnologies, The Biotechnology Centre, University of Yaounde I, BP 8094, Yaounde, Cameroon.
Benjamin Ewa UbiDepartment of Biotechnology, Ebonyi State University, P.M.B. 53, Abakaliki, Nigeria.
Godfrey Okoye University · NGEbonyi State University · NGUniversité de Yaoundé I · CMUniversity of Wolverhampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association between ABCC8 gene C49620T polymorphism and type 2 diabetes (T2D) in populations of diverse ethnic backgrounds has been reported. However, such occurrence in an African population is yet to be established. This case-control study involving 73 T2D and 75 non-diabetic (ND) patients investigated the occurrence of this polymorphism among T2D patients in Nigeria and assessed its relationship with body lipids of patients.

methodsDemographic and clinical characteristics of patients were collected and lipid profile indices including total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL) were assayed. Restriction fragment length polymorphism-PCR (RFLP-PCR) was employed to genotype the ABCC8-C49620T polymorphism using PstI restriction enzyme.

resultsThis study revealed significantly (p < 0.05) higher prevalence of the T allele of the ABCC8 gene in T2D patients (33.1%) compared to ND patients (28.0%). The mutant TT genotype was also higher than the CC and CT genotypes in T2D patients compared to ND patients but did not show any significant risk (p>0.05) of T2D for the unadjusted codominant, dominant and recessive models. Following age adjustment, the mutant genotypes (CT and TT) showed significant (p<0.05) risk of T2D for all the models with the recessive model presenting the greatest risk of T2D (OR: 2.39, 95% CI: 1.16-4.91, p<0.018). The TT genotype significantly (p<0.05) associated with high level of HDL and reduced levels of TC, TG and LDL in non-diabetic patients but was not associated with any of the demographic and clinical characteristics among T2D patients.

conclusionsABCC8 C49620T polymorphism showed possible association with T2D marked by predominance of the mutant TT genotype in T2D patients. However, the relationship between TT genotype and lipid abnormalities for possible beneficial effect on people suffering from T2D is unclear.

Indexed as

Point MutationAllelesBlack PeopleCase-Control StudiesDiabetes Mellitus, Type 2FemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMiddle AgedNigeriaSulfonylurea ReceptorsABCC8 protein, humanSulfonylurea ReceptorsABCC8 geneC49620T variantGenotypingNigeriaType 2 diabetes

Identifiers

PMID29751826
PMCPMC5948806
OpenAlexW2806366649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.